Meta-analysis in cancer genetics

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 1, 2010, Pages 33-38

  Pabalan, Noel A ^a  

^a SAINT LOUIS UNIVERSITY   (Philippines)

Author keywords

Cancer; Genetics; Meta analysis

Indexed keywords

GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; HUMAN; META ANALYSIS (TOPIC); NEOPLASM;

GENETIC ASSOCIATION STUDIES; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 77955800776     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Alcasabas P, Ravindranath Y, Goyette G, et al (2008). 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children. Pediatr Blood Cancer, 51, 178-82.
2. Ameyaw MM, Tayeb M, Thornton N, et al (2002). Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer. J Hum Genet, 47, 172-5.
3. Bai Y, Gao J, Zou D, Li Z (2007). Is MEDLINE alone enough for a meta-analysis? Aliment Pharmacol Ther, 26, 125-6; author reply 126.
4. Brennan P (2002). Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis, 381-7.
5. Cardon LR, Bell JI (2001). Association study designs for complex diseases. Nat Rev Genet, 2, 91-9.
6. Colhoun HM, McKeigue PM, Davey Smith G (2003). Problems of reporting genetic associations with complex outcomes. Lancet, 361, 865-72.
7. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
8. Department of Health (2004). Philippine Health Statistics.
9. Egger M, Smith GD, Phillips AN (1997). Meta-analysis: principles and procedures. BMJ, 315, 1533-7.
10. Galbraith RF (1988). A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med, 7, 889-94.
11. Giguere Y, Dewailly E, Brisson J, et al (2001). Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res, 61, 5869-74.
12. Gonzalez FJ (1995). Genetic polymorphism and cancer susceptibility: 14th Sapporo Cancer Seminar. Cancer Res, 55, 710-5.
13. Gotzsche PC (2000). Why we need a broad perspective on meta-analysis. It may be crucially important for patients. BMJ, 321, 585-6.
14. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
15. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002). A comprehensive review of genetic association studies. Genet Med, 4, 45-61.
16. Ioannidis JP (2004). The value of meta-analysis in rheumatology research. Autoimmun Rev, 3 Suppl 1, S57-9.
17. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001). Replication validity of genetic association studies. Nat Genet, 29, 306-9.
18. Liede A, Zhang W, De Leon Matsuda ML, Tan A, Narod SA (2003). Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines. Cancer Epidemiol Biomarkers Prev, 12, 848-52.
19. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003). Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet, 33, 177-82.
20. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
21. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J (2005). The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol, 34, 1319-28.
22. Munafo MR, Flint J (2004). Meta-analysis of genetic association studies. Trends Genet, 20, 439-44.
23. Onay UV, Aaltonen K, Briollais L, et al (2008). Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk. BMC Cancer, 8, 6.
24. Ozcelik H, Jarjanazi, H., Pabalan, N (2005). Cloning and characterization of expanded CAG-repeat containing sequence(s): identification of candidate breast cancer predisposition genes. Genetic Engineering Molec Biol, 41, A964244.
25. Pabalan N, Bapat B, Sung L, et al (2008). Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 17, 2773-81.
26. Pabalan N, Francisco-Pabalan O, Sung L, Jarjanazi H, Ozcelik H (2010). Meta-analysis of two polymorphisms, Lys751Gln and Asp312Asn, in the DNA repair gene, XPD (ERCC2) with breast cancer. Breast Cancer Res Treat, 17, 27
27. Risch N, Merikangas K (1996). The future of genetic studies of complex human diseases. Science, 273, 1516-7.
28. Sachidanandam R, Weissman D, Schmidt SC, et al (2001). A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 409, 928-33.
29. Sagoo GS, Little J, Higgins JP (2009). Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med, 6, e28.
30. Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 283, 2008-12.
31. Taioli E (2005). Biomarkers of genetic susceptibility to cancer: applications to epidemiological studies. Future Oncol, 1, 51-6.
32. Yuan Y, Hunt RH (2009). Systematic reviews: the good, the bad, and the ugly. Am J Gastroenterol, 104, 1086-92.
33. Zintzaras E, Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol, 28, 123-37.
34. Zintzaras E, Lau J (2008). Trends in meta-analysis of genetic association studies. J Hum Genet, 53, 1-9.
35. Zondervan KT, Cardon LR (2004). The complex interplay among factors that influence allelic association. Nat Rev Genet, 5, 89-100.